Literature DB >> 3731922

Effects of erythromycin, josamycin and spiramycin on rat polymorphonuclear leukocyte chemotaxis.

A Eyraud, J Descotes, J Y Lombard, A Laschi-Loquerie, P Tachon, C Veysseyre, J C Evreux.   

Abstract

The effects of three macrolide antibiotics were studied on rat polymorphonuclear leukocyte chemotaxis. Rats were given 25 mg/kg twice a day of either erythromycin, josamycin or spiramycin by gastric intubation for 5 days. In all cases, chemotaxis was found to be impaired by 10-20% only. As macrolides are known to reach high intracellular concentrations within polymorphonuclear leukocytes, our results suggest that these antibiotics are unlikely to exert a deleterious influence on the chemotactic response of treated patients.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3731922     DOI: 10.1159/000238438

Source DB:  PubMed          Journal:  Chemotherapy        ISSN: 0009-3157            Impact factor:   2.544


  7 in total

1.  Efficacy of erythromycin lactobionate for treating Pseudomonas aeruginosa bacteremia in mice.

Authors:  Y Hirakata; M Kaku; K Tomono; K Tateda; N Furuya; T Matsumoto; R Araki; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-06       Impact factor: 5.191

Review 2.  Lung infections. 3. Pseudomonas aeruginosa and other related species.

Authors:  R Wilson; R B Dowling
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

3.  Preventive effect of erythromycin on experimental bleomycin-induced acute lung injury in rats.

Authors:  A Azuma; T Furuta; T Enomoto; Y Hashimoto; K Uematsu; N Nukariya; A Murata; S Kudoh
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

4.  Potential effects of erythromycin on host defense systems and virulence of Pseudomonas aeruginosa.

Authors:  Y Hirakata; M Kaku; R Mizukane; K Ishida; N Furuya; T Matsumoto; K Tateda; K Yamaguchi
Journal:  Antimicrob Agents Chemother       Date:  1992-09       Impact factor: 5.191

5.  Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.

Authors:  H Suzaki; K Asano; S Ohki; K Kanai; T Mizutani; T Hisamitsu
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

6.  Suppressive activity of a macrolide antibiotic, roxithromycin on co-stimulatory molecule expression on mouse splenocytes in vivo.

Authors:  K Kawazu; M Kurokawa; K Asano; A Mita; M Adachi
Journal:  Mediators Inflamm       Date:  2000       Impact factor: 4.711

7.  Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.

Authors:  T Shimane; K Asano; M Suzuki; T Hisamitsu; H Suzaki
Journal:  Mediators Inflamm       Date:  2001-12       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.